Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ FTSJD1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA559681
Description
Immunogen sequence: AIHPLLSKMT LNFGTEMKRK ALFPHHVIPD SFLKRHEECC VFFHKYQLET ISENIRLFEC MGKAEQEKLN NLRDCAIQYF MQKFQLKHLS RNNWLVK Highest antigen sequence identity to the following orthologs: Mouse - 84%, Rat - 81%.
S-adenosyl-L-methionine-dependent methyltransferase that mediates mRNA cap2 2'-O-ribose methylation to the 5'-cap structure of mRNAs. Methylates the ribose of the second nucleotide of a m(7)GpppG-capped mRNA and small nuclear RNA (snRNA) (cap0) to produce m(7)GpppRmpNm (cap2). Recognizes a guanosine cap on RNA independently of its N(7) methylation status. Display cap2 methylation on both cap0 and cap1. Displays a preference for cap1 RNAs.
Specifications
FTSJD1 | |
Polyclonal | |
Unconjugated | |
CMTR2 | |
adrift homolog; AFT; AU022703; C730036L12Rik; cap methyltransferase 2; cap2 2'O-ribose methyltransferase 2; Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2; Cmtr2; FtsJ methyltransferase domain containing 1; ftsJ methyltransferase domain-containing protein 1; ftsjd1; HMTr2; hypothetical protein LOC406742; MTr2; Protein adrift homolog; RGD1309394; wu:fj48c05; zgc:55686 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
55783 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q8IYT2 | |
CMTR2 | |
Recombinant protein corresponding to Human FTSJD1. Recombinant protein control fragment (Product #RP-98779). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction